Authors: Tecimer, C Doering, DL Goldsmith, LJ Meyer, JS Abdulhay, G Wittliff, JL

Citation: C. Tecimer et al., Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer, GYNECOL ONC, 80(1), 2001, pp. 48-55

Authors: Tecimer, C Doering, DL Goldsmith, LJ Meyer, JS Abdulhay, G Wittliff, JL

Citation: C. Tecimer et al., Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer, INT J GYN C, 10(5), 2000, pp. 372-381

Authors: Tecimer, C Loy, BA Martin, AW

Citation: C. Tecimer et al., Acute myeloblastic leukemia (MO) with an unusual chromosomal abnormality: Translocation (1;14)(p13;q32), CANC GENET, 111(2), 1999, pp. 175-177